Chemotherapy has long forced patients to choose between fighting their cancer and living with nerve pain that can linger for years after treatment ends. Now a wave of basic science and early clinical ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests. These patients might experience loss of balance and coordination, ...

Halneuron, a NaV 1.7 sodium channel inhibitor, is being tested for chemotherapy-induced neuropathic pain, offering a potential opioid alternative. Previous trials showed Halneuron significantly ...

Dogwood Therapeutics, Inc. has announced the dosing of the first patient in its Phase 2b clinical trial, HALT-CINP, which studies Halneuron® as a treatment for chemotherapy-induced neuropathic pain.

Peer-reviewed results published in Supportive Care in Cancer, the official journal of the Multinational Association of Supportive Care in Cancer (MASCC). The study, "Multi-institutional, randomized, ...

Patients might experience weakness, loss of balance and coordination, numbness or tingling WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Four in every 10 cancer patients treated with chemotherapy ...

Spiny Pufferfish <br>Experienced chefs know how to slice into the pufferfish to avoid the deadly tetrodotoxin, which disrupts the nervous system and can cause fatal paralysis of important muscles that ...